165,100 Shares in Inspire Medical Systems, Inc. $INSP Bought by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 165,100 shares of the company's stock, valued at approximately $7,365,000. Canada Pension Plan Investment Board owned 0.57% of Inspire Medical Systems as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. CWM LLC boosted its holdings in shares of Inspire Medical Systems by 216.1% in the fourth quarter. CWM LLC now owns 354 shares of the company's stock valued at $33,000 after acquiring an additional 242 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Inspire Medical Systems by 1,115.4% during the first quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company's stock worth $33,000 after acquiring an additional 580 shares during the period. Havemeyer Place LP purchased a new position in Inspire Medical Systems during the fourth quarter worth about $39,000. Smartleaf Asset Management LLC raised its holdings in Inspire Medical Systems by 84.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company's stock worth $42,000 after purchasing an additional 205 shares in the last quarter. Finally, Versant Capital Management Inc lifted its position in Inspire Medical Systems by 379.0% in the second quarter. Versant Capital Management Inc now owns 958 shares of the company's stock valued at $43,000 after purchasing an additional 758 shares during the period. Hedge funds and other institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Trading Up 1.1%

INSP stock opened at $61.49 on Friday. The company's 50-day moving average price is $53.10 and its 200 day moving average price is $52.50. Inspire Medical Systems, Inc. has a 52 week low of $38.91 and a 52 week high of $147.03. The company has a market cap of $1.78 billion, a P/E ratio of 13.31, a P/E/G ratio of 4.67 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The company had revenue of $200.58 million during the quarter, compared to analysts' expectations of $194.72 million. During the same period last year, the company posted $0.45 earnings per share. The firm's quarterly revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, equities research analysts expect that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on INSP shares. KeyCorp reaffirmed a "sector weight" rating on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Freedom Capital raised Inspire Medical Systems to a "strong-buy" rating in a report on Tuesday, June 30th. JPMorgan Chase & Co. lifted their price target on Inspire Medical Systems from $54.00 to $60.00 and gave the company a "neutral" rating in a research note on Tuesday, August 4th. Piper Sandler upped their price objective on Inspire Medical Systems from $55.00 to $60.00 and gave the stock a "neutral" rating in a report on Tuesday, August 4th. Finally, Mizuho upped their price objective on Inspire Medical Systems from $55.00 to $65.00 and gave the stock an "outperform" rating in a report on Tuesday, August 4th. Two analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $66.19.

Insider Buying and Selling at Inspire Medical Systems

In related news, insider Jason P. Kelly sold 963 shares of the company's stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $59.55, for a total value of $57,346.65. Following the sale, the insider owned 18,985 shares in the company, valued at $1,130,556.75. This represents a 4.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 2.20% of the stock is currently owned by corporate insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company's flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source